Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1841
https://www.valueinhealthjournal.com/article/S1098-3015(16)33207-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1739
First Page :
A666
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33207-7&doi=10.1016/j.jval.2016.09.1841